Pharmaceutical Manufacturer

U.S. pharmacy organizations unite in call for PBM reform by year end
“It Is Past Time for Action” say groups representing pharmacy as they call on U.S. Congress to act immediately to reform the Pharmacy Benefits management system that has decimated community pharmacy.
Changes coming to compounding and repackaging policy framework for Alberta pharmacists
Beginning on April 1, 2025, community and satellite pharmacies in Alberta will be authorized to only accept C&R drugs services from C&R pharmacies licensed in the province.

New Canadian recommendations for treatment of HER2+ breast cancer

REAL Canadian Breast Cancer Alliance provides evidence-based consensus guidance on treatment of early and metastatic HER2+ breast cancer.
New product: Uplizna

Get the info you need on this new product, part of our drug news roundup for December.
New product: Amvuttra

Get the info you need on this new product, part of our drug news roundup for December.
Supreme Court affirms constitutionality of B.C. law on opioid health costs recovery

Section 11 of B.C.’s Opioid Damages and Health Care Costs Recovery Act allows the province to bring an action against opioid manufacturers and distributors on behalf of multiple governments.
QUIZ: Do you know enough to help stop the spread of antimicrobial resistance?

World antimicrobial resistance (AMR) week runs from November 18 to 24. From appropriate prescribing to prevention of infection, test how much you know about antimicrobial resistance.
Metastatic melanoma: How patients are gaining a decade with immunotherapy

The prognosis for advanced melanoma is improving, thanks to a combination of immune checkpoint inhibitors, new research shows.
What’s up in Rx drug trends? Pharmacist prescribing for one thing

New report from GreenShield highlights trends in prescription drug use trends and pharmacist prescribing based on data from 2023 member claims.
23andMe cuts 40% of its workforce and discontinues therapeutics division

The company said it plans to wind down ongoing clinical trials ‘as quickly as practical.’

U.S. pharmacy organizations unite in call for PBM reform by year end

Changes coming to compounding and repackaging policy framework for Alberta pharmacists

New Canadian recommendations for treatment of HER2+ breast cancer

New product: Uplizna

New product: Amvuttra

Supreme Court affirms constitutionality of B.C. law on opioid health costs recovery

QUIZ: Do you know enough to help stop the spread of antimicrobial resistance?

Metastatic melanoma: How patients are gaining a decade with immunotherapy

What’s up in Rx drug trends? Pharmacist prescribing for one thing

23andMe cuts 40% of its workforce and discontinues therapeutics division